Claudine Bruck - 10 Sep 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2025, 09:17:18 UTC
Prior SEC filing
22 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Claudine Bruck

Key filing fact

Claudine Bruck filed Form 4 for Annovis Bio, Inc. (ANVS) on 12 Nov 2025.

Key facts

  • This page summarizes Claudine Bruck's Form 4 filing for Annovis Bio, Inc. (ANVS).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Nov 2025, 09:17.

Change

  • Previous filing in this sequence was filed on 22 Nov 2023.
  • Current net transaction value: +$1,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001733680 Primary reporting owner

Bruck Claudine

Relationship
Director
Address
C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN
Signature
/s/ Claudine Bruck
Signature date
12 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANVS transaction

Common Stock

Options Exercise

Transaction value
$1,000
Shares
+7,142
Change %
+109%
Price
$0.1400
Shares after
13,709
Date
10 Sep 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANVS transaction Derivative

Option

Options Exercise

Transaction value
$0
Shares
-7,142
Change %
-100%
Price
$0.000000
Shares after
0
Date
10 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,142
Exercise price
$0.1400
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .